Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 26 publications
A Framework for Prioritizing Novel Agents in Malignant Peripheral Nerve Sheath Tumor Trials: A report from the Neurofibromatosis Clinical Trials Consortium.
Journal: Neuro-oncology
Published: May 13, 2026
Identifying caregiver-reported modifiable barriers to pediatric oncology clinical trial enrollment and participation.
Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
Published: July 15, 2025
Phase II study of axitinib in patients with NF2-related schwannomatosis and progressive vestibular schwannomas.
Journal: Neuro-oncology advances
Published: June 27, 2025
The Prostate is a Common Site of Disease in Patients with MEN2B and Medullary Thyroid Carcinoma.
Journal: Endocrine-related cancer
Published: September 08, 2024
Tumor Volume Doubling Time of Less Than 1 Year Is Associated With a Higher Risk of Death From Medullary Thyroid Cancer.
Journal: The Journal of clinical endocrinology and metabolism
Published: August 01, 2024
Phase I trial of Ganitumab plus Dasatinib to Cotarget the Insulin-Like Growth Factor 1 Receptor and Src Family Kinase YES in Rhabdomyosarcoma.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: March 24, 2023
Outcome of Patients With Malignant Peripheral Nerve Sheath Tumors Enrolled on Sarcoma Alliance for Research Through Collaboration (SARC) Phase II Trials.
Journal: The oncologist
Published: August 17, 2022
MEK inhibitors for neurofibromatosis type 1 manifestations: Clinical evidence and consensus.
Journal: Neuro-oncology
Published: July 05, 2022
Management of neurofibromatosis type 1-associated plexiform neurofibromas.
Journal: Neuro-oncology
Published: June 03, 2022
Fracture Risk in Pediatric Patients With MEN2B.
Journal: The Journal of clinical endocrinology and metabolism
Published: May 24, 2022
Last Updated: 09/26/2026